Natural product-based therapy for p53-mutated human Cancers: Nonivamide increases the expression of tumor suppressor p53 homologue TAp63 via down regulation of its target gene, 2/March/2015, 9.17 am

Natural product-based therapy for p53-mutated human Cancers: Nonivamide increases the expression of tumor suppressor p53 homologue TAp63 via down regulation of its target gene, 2/March/2015, 9.17 am

Natural product-based therapy for p53-mutated human Cancers: Nonivamide increases the expression of tumor suppressor p53 homologue TAp63 via down regulation of its target gene, 2/March/2015, 9.17 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Natural product-based therapy for p53-mutated human Cancers: Nonivamide increases the expression of tumor suppressor p53 homologue TAp63  via down regulation of its target gene, 2/March/2015,  9.17 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance:  This study suggests, for the first time, Nonivamide, by suppressing the expression of its target gene, it may increase the expression of TAp63. Thus, pharmacological formulations encompassing “Nonivamide or its analouges”  can be used to inhibit the progression of human tumors.

Amount: $ 500*

Undisclosed information: How Nonivamide increases the expression of cancer suppressor p53 homologue TAp63

* Research cooperation